深圳华拓至远叁号投资被出具警示函，涉违规减持

Core Viewpoint - The Guangdong Securities Regulatory Bureau has issued an administrative regulatory decision against Shenzhen Huatuo Zhiyuan No. 3 Investment Enterprise (Limited Partnership) for violating regulations regarding the reduction of shares prior to the IPO of Guangdong Guokang Biochemical Technology Co., Ltd. [1] Group 1: Regulatory Actions - The decision states that Shenzhen Huatuo Zhiyuan No. 3 Investment Enterprise, as a pre-IPO shareholder, committed to not reducing its shares below the IPO price of 41.78 yuan per share, but reduced 29,800 shares at 41.63 yuan per share on November 3, 2025, violating the regulations [1] - The Guangdong Securities Regulatory Bureau has decided to issue a warning letter to the enterprise and record it in the securities and futures market integrity file [2] Group 2: Compliance and Remedial Actions - Following the violation, the enterprise repurchased the shares it improperly reduced and paid the price difference to Guokang Biochemical [1] - The regulatory body emphasized the need for the enterprise to learn from this incident, strengthen its understanding of securities laws and regulations, and ensure compliance in future share reduction activities [2]